Developing selective histone deacetylases (HDACs) inhibitors through ebselen and analogs
Yuren Wang,1 Jason Wallach,2 Stephanie Duane,1 Yuan Wang,1 Jianghong Wu,1 Jeffrey Wang,1 Adeboye Adejare,2 Haiching Ma1 1Reaction Biology Corp., Malvern, 2Department of Pharmaceutical Sciences, Philadelphia College of Pharmacy, University of the Sciences, Philadelphia, PA, USA Abstract: Histone deac...
Saved in:
Main Authors: | Wang Y (Author), Wallach J (Author), Duane S (Author), Wu J (Author), Wang J (Author), Adejare A (Author), Ma H (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2017-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Histone Deacetylase (HDAC) Inhibitors for the Treatment of Schistosomiasis
by: Ehab Ghazy, et al.
Published: (2022) -
The potential for histone deacetylase (HDAC) inhibitors as cestocidal drugs.
by: Hugo Rolando Vaca, et al.
Published: (2021) -
Structure-Based Identification of Novel Histone Deacetylase 4 (HDAC4) Inhibitors
by: Rupesh Agarwal, et al.
Published: (2024) -
Induction of histone deacetylases (HDACs) in human abdominal aortic aneurysm: therapeutic potential of HDAC inhibitors
by: María Galán, et al.
Published: (2016) -
The effects of the Histone Deacetylase (HDAC) Inhibitor 4-Phenylbutyrate on gap junction conductance and permeability
by: Joshua eKaufman, et al.
Published: (2013)